James N. Hutton-Mills

UBS Asset Management (UK) Ltd. (UBS-UK) is the Great Britain-based investment subsidiary of UBS Asset Management Holdings Ltd., itself a subsidiary of UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. Founded in 1981 as Phillips & Drew Investment Management Ltd., the firm merged with UBS Asset Management in 2000 to form UBS Asset Management Ltd., which became UBS Global Asset Management (UK) Ltd. in 2002. They changed their name to UBS Asset Management (UK) Ltd. in 2015. Headquartered in London, UBS-UK provides asset management services to corporate and public pension plans, sovereign institutions, endowments and municipalities, charities, insurance companies, wholesale intermediaries, financial institutions, and private clients.

UBS AG's (NYSE: UBS) New York City-based wealth management arm is known as UBS Private Banking (US). The firm provides a range of customized wealth management products and services for private clients.

Citadel Advisors LLC is a SEC-registered investment advisor and hedge fund manager headquartered in Miami, Florida. The firm was founded in 1990 by Kenneth Griffin and is wholly-owned by Citadel Advisors Holdings LP, ultimately held by GFH HFEVA LLC. Citadel Advisors manages private investment funds that are offered exclusively to sophisticated investors.

Cheyne Capital Management (UK) LLP (Cheyne) is the alternative investment fund management subsidiary of Cheyne Capital Management Ltd., ultimately held by Novatrust Ltd. in Great Britain. The firm was founded by Jonathan Lourie and Stuart Fiertz in 2000. Headquartered in London, Cheyne manages the Cheyne Funds for a range of clients which include pension funds, insurance companies, sovereign wealth funds, endowments, banks, funds of funds and other financial institutions as well as family offices and high net-worth individuals.

Thames River Capital LLP (TRC) is a specialist fund management firm headquartered in London, UK. The firm was founded in 1998 and is a subsidiary of Columbia Threadneedle Capital (UK) Ltd., ultimately held by Ameriprise Financial, Inc. (NYSE: AMP) in the US. TRC provides specialist fund management services to professional investors and institutions in the UK and worldwide, through several single and multi-manager funds.

Morgan Stanley & Co. International Plc (MSCI) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Morgan Stanley Investments (UK), ultimately held by Morgan Stanley (NYSE: MS) in the US. MSCI provides a range of brokerage services to corporations, governments and financial institutions.

WMG Advisors LLP is an independent, Great Britain-based wealth management firm which was founded in 2004 by Mehmet Dalman. Headquartered in London, the firm offers single strategy hedge funds and discretionary wealth management services to institutions, endowment funds, family offices and high net-worth individuals.

GED Capital Development SGEIC SA (Conexo Ventures) is a venture capital firm founded in 1996 by Robert Micheal Luke. The firm is headquartered in Madrid, Spain.

The FXCM Group provides online foreign exchange, or FX, trading and related services. It operates as a holding company. The firm operates through two segments: Retail Trading and Institutional Trading. The company was founded by David Sakhai, Kenneth A. Grossman, Dror Niv, Eduard Yusupov and William Ahdout in 1999 and is headquartered in New York, NY.

Tyrus Capital LLP engages in the provision of investment advice. The company was founded on April 4, 2009 and is headquartered in London, the United Kingdom.

Part of Barclays PLC, Barclays Wealth Management Jersey Ltd. is a British company that provides banking services. The company is based in St. Heiler, UK.

Part of Delta Capita Group Ltd., Delta Capita Ltd. is a British company that provides business consulting, technology solutions and managed services for financial institutions. The company is based in Canary Wharf, UK. The company was founded in 2010. The CEO is Booker Joe Channer.

Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York.